These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33619893)

  • 41. Monitoring of Daily Body Weight and Intrathoracic Impedance in Heart Failure Patients With a High Risk of Volume Overload Decompensation.
    Gudmundsson K; Lyngå P; Rosenqvist M; Braunschweig F
    Clin Cardiol; 2016 Aug; 39(8):446-52. PubMed ID: 27175605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Old markers, new approach to assessment of risk in heart failure.
    Kodziszewska K; Leszek P; Korewicki J; Piotrowski W
    Kardiol Pol; 2015; 73(6):387-95. PubMed ID: 25563469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.
    Nassif ME; Windsor SL; Tang F; Khariton Y; Husain M; Inzucchi SE; McGuire DK; Pitt B; Scirica BM; Austin B; Drazner MH; Fong MW; Givertz MM; Gordon RA; Jermyn R; Katz SD; Lamba S; Lanfear DE; LaRue SJ; Lindenfeld J; Malone M; Margulies K; Mentz RJ; Mutharasan RK; Pursley M; Umpierrez G; Kosiborod M
    Circulation; 2019 Oct; 140(18):1463-1476. PubMed ID: 31524498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
    Conraads VM; Tavazzi L; Santini M; Oliva F; Gerritse B; Yu CM; Cowie MR
    Eur Heart J; 2011 Sep; 32(18):2266-73. PubMed ID: 21362703
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.
    Linde C; Abraham WT; Gold MR; St John Sutton M; Ghio S; Daubert C;
    J Am Coll Cardiol; 2008 Dec; 52(23):1834-1843. PubMed ID: 19038680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
    Small RS; Wickemeyer W; Germany R; Hoppe B; Andrulli J; Brady PA; Labeau M; Koehler J; Sarkar S; Hettrick DA; Tang WH
    J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracardiac impedance after cardiac resynchronization therapy is a novel predictor for worsening of heart failure.
    Suzuki H; Nodera M; Kamioka M; Kaneshiro T; Kamiyama Y; Takeishi Y
    Heart Vessels; 2017 Aug; 32(8):926-931. PubMed ID: 28181011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of thoracic impedance trends for implant-based remote monitoring in heart failure patients - Results from the (J-)HomeCARE-II Study.
    Maier SKG; Paule S; Jung W; Koller M; Ventura R; Quesada A; Bordachar P; García-Fernández FJ; Schumacher B; Lobitz N; Takizawa K; Ando K; Adachi K; Shoda M
    J Electrocardiol; 2019; 53():100-108. PubMed ID: 30739055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
    Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
    Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of short-term omission of daily medication on the pathophysiology of heart failure.
    Dovancescu S; Pellicori P; Mabote T; Torabi A; Clark AL; Cleland JGF
    Eur J Heart Fail; 2017 May; 19(5):643-649. PubMed ID: 28295907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy.
    Mallick A; Gandhi PU; Gaggin HK; Ibrahim N; Januzzi JL
    JACC Heart Fail; 2016 Sep; 4(9):749-55. PubMed ID: 27179830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proposal for heart failure progression based on the 'chloride theory': worsening heart failure with increased vs. non-increased serum chloride concentration.
    Kataoka H
    ESC Heart Fail; 2017 Nov; 4(4):623-631. PubMed ID: 29154432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.
    Emdin M; Aimo A; Vergaro G; Bayes-Genis A; Lupón J; Latini R; Meessen J; Anand IS; Cohn JN; Gravning J; Gullestad L; Broch K; Ueland T; Nymo SH; Brunner-La Rocca HP; de Boer RA; Gaggin HK; Ripoli A; Passino C; Januzzi JL
    J Am Coll Cardiol; 2018 Nov; 72(19):2309-2320. PubMed ID: 30384887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of laboratory haemoconcentration measures with filling pressures obtained via pulmonary arterial pressure sensors in ambulatory heart failure patients.
    Almufleh A; Desai AS; Fay R; Ferreira JP; Buckley LF; Mehra MR; Rossignol P; Zannad F
    Eur J Heart Fail; 2020 Oct; 22(10):1907-1911. PubMed ID: 32353199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evaluation of sleep apnea, detected by 24-hour ECG Holter monitoring analysis in patients with stable coronary artery disease and ischemic heart failure - correlations with clinical data].
    Frączek-Jucha M; Rostoff P; Łach J; Nessler J; Gackowski A
    Pol Merkur Lekarski; 2017 Jun; 42(252):231-235. PubMed ID: 28662007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT.
    Skali H; Dwyer EM; Goldstein R; Haigney M; Krone R; Kukin M; Lichstein E; McNitt S; Moss AJ; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2014 May; 16(5):560-5. PubMed ID: 24578164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Utility of heart rate turbulence and T-wave alternans to assess risk for readmission and cardiac death in hospitalized heart failure patients.
    Yamada S; Yoshihisa A; Sato Y; Sato T; Kamioka M; Kaneshiro T; Oikawa M; Kobayashi A; Suzuki H; Ishida T; Takeishi Y
    J Cardiovasc Electrophysiol; 2018 Sep; 29(9):1257-1264. PubMed ID: 29777559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adding serial N-terminal pro brain natriuretic peptide measurements to optimal clinical management in outpatients with systolic heart failure: a multicentre randomized clinical trial (NorthStar monitoring study).
    Schou M; Gustafsson F; Videbaek L; Andersen H; Toft J; Nyvad O; Ryde H; Fog L; Jensen JC; Nielsen OW; Lind-Rasmussen S; Abdulla J; Hildebrandt PR;
    Eur J Heart Fail; 2013 Jul; 15(7):818-27. PubMed ID: 23507787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.